Patent Assignment
Reel/Frame 062296/0621
Assignment of Assignor's Interest
Recorded: 2023-01-06
Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2023-01-03
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties
(11)
Treatment of Depression in Certain Patient Populations
Application:
63/373,040 →
Treatment of Depression in Certain Patient Populations
Application:
63/401,541 →
Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan
Application:
17/937,948 →
Publication:
US US20230277504A1
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Application:
18/056,804 →
Publication:
US US20230096437A1
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Application:
18/056,848 →
Publication:
US US20230142244A1
Bupropion as a Modulator of Drug Activity
Application:
63/385,205 →
Bupropion as a Modulator of Drug Activity
Application:
18/061,091 →
Publication:
US US20230277478A1
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Application:
18/062,236 →
Publication:
US US20230100008A1
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Application:
18/062,273 →
Publication:
US US20230270740A1
Bupropion as a Modulator of Drug Activity
Bupropion as a Modulator of Drug Activity
Application:
18/066,739 →
Publication:
US US20230131854A1